
Agios Pharmaceuticals Inc
NASDAQ:AGIO

Intrinsic Value
The intrinsic value of one
AGIO
stock under the Base Case scenario is
28.79
USD.
Compared to the current market price of 32.09 USD,
Agios Pharmaceuticals Inc
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Agios Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Agios Pharmaceuticals Inc
Balance Sheet Decomposition
Agios Pharmaceuticals Inc
Current Assets | 968.6m |
Cash & Short-Term Investments | 893.4m |
Receivables | 3.3m |
Other Current Assets | 71.9m |
Non-Current Assets | 586.9m |
Long-Term Investments | 531.3m |
PP&E | 50.9m |
Other Non-Current Assets | 4.7m |
Free Cash Flow Analysis
Agios Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Agios Pharmaceuticals Inc
Revenue
|
37m
USD
|
Cost of Revenue
|
-4.6m
USD
|
Gross Profit
|
32.4m
USD
|
Operating Expenses
|
616.4m
USD
|
Operating Income
|
648.8m
USD
|
Other Expenses
|
17.1m
USD
|
Net Income
|
666m
USD
|
AGIO Profitability Score
Profitability Due Diligence
Agios Pharmaceuticals Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Agios Pharmaceuticals Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
AGIO Solvency Score
Solvency Due Diligence
Agios Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Agios Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AGIO Price Targets Summary
Agios Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AGIO
is 56.44 USD
with a low forecast of 38.38 USD and a high forecast of 77.7 USD.
Dividends
Current shareholder yield for AGIO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AGIO
stock under the Base Case scenario is
28.79
USD.
Compared to the current market price of 32.09 USD,
Agios Pharmaceuticals Inc
is
Overvalued by 10%.